Micron Biomedical

Press Releases

Micron Biomedical Announces The Lancet Publication of Positive Phase 1/2 Data From First Clinical Trial of Needle-Free Vaccines in Children

May 1, 2024

Micron Biomedical Appoints Global Health Pioneer and Champion of Vaccine Access, Dr. Seth Berkley, as Scientific Advisor to the CEO

February 27, 2024

Micron Biomedical Receives $23.6 Million to Accelerate Commercial Manufacturing of Needle-Free Vaccines and to Help Eradicate Measles

November 16, 2023

Micron Biomedical Appoints Brian Bernick, MD as Chairman of Its Board of Directors

August 9, 2023

Micron Biomedical Announces Positive Measles and Rubella Vaccination Results from First Clinical Trial of Microarray Injection-Free Vaccine Delivery in Children

May 17, 2023

Micron Biomedical Extends Series A to $17 Million to Bring Needle-Free Drugs and Vaccines to Market

May 10, 2023

Micron Biomedical Secures Series A Financing to Commercialize MAP Technology for Self-Administration of Drugs and Vaccines without Needles

November 28, 2022

Micron Biomedical Presents at the White House Summit on the Future of COVID-19 Vaccines

July 26, 2022

Micron Biomedical Initiates First-Ever Microneedle Vaccine Clinical Trial in Children

July 13, 2021

Micron receives contract from CDC to manufacture IRV microneedle patches

November 12, 2020

Top 10 Emerging Technologies of 2020

November 10, 2020

Micron developing microneedle technology for self-administration of vaccines and therapeutics

November 3, 2020